Newsroom - Page 9

In a study that will surely set off alarms, Kansas researcher Kyle Chapman found that those with a college degree gain more benefits from good diets and exercise than those without the same education.
The incidence of hospitalizations for pulmonary hypertension among children has doubled from 1997 to 2012 with associated costs growing to $3.12 billion.
Results for the cardiovascular outcomes trial on the SGLT2 inhibitor mark the first time one of the newer diabetes drugs has produced benefits since the FDA began looking closely at these effects. Full data will be presented next month at the European Association for the Study of Diabetes.
Millions of exchange plan enrollees are missing out on subsidies available under the Affordable Care Act because they picked a non-qualifying health plan.
Conducted by researchers at the Memorial Sloan Kettering Cancer Center, phase 2 results from a basket trial evaluated the efficacy of vemurafenib on nonmelanoma BRaf V600-mutated cancers in 122 patients across 23 global centers.
Americans support more transparency in setting drug prices and letting Medicare negotiate with the pharmaceutical companies, according to the Kaiser Family Foundation poll.
The ITCA 650 device, which delivers tiny doses of exenatide, could be a game changer in solving the problem of medication adherence. An application for FDA approval is expected in the first half of 2016.
As California reduced the number of adults ages 19 to 64 years without health insurance by 15.5% from 2013 to 2014, Medi-Cal enrollment among the same age group rose from 12.9% to 19.2% during the same time period, according to new data from the UCLA Center for Health Policy Research.